ENTRY       D12420                      Drug
NAME        Licaminlimab (USAN/INN)
FORMULA     C1175H1788N322O374S10
EXACT_MASS  26712.7998
MOL_WEIGHT  26729.3522
SEQUENCE    MEIVMTQSPS TLSASVGDRV IITCQSSQSV YGNIWMAWYQ QKPGRAPKLL IYQASKLASG
            VPSRFSGSGS GAEFTLTISS LQPDDFATYY CQGNFNTGDR YAFGQGTKLT VLGGGGGSGG
            GGSGGGGSGG GGSEVQLVES GGGSVQPGGS LRLSCTASGF TISRSYWICW VRQAPGKGLE
            WVGCIYGDND ITPLYANWAK GRFTISRDTS KNTVYLQMNS LRAEDTATYY CARLGYADYA
            YDLWGQGTTV TVSS
            (Disulfide bridge: 24-91, 155-231, 169-184)
  TYPE      Peptide
EFFICACY    Anti-inflammatory, Immunomodulator, Anti-TNF-alpha antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of uveitis and dry eye
TARGET      TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNF (TNFA, TNFSF2)
                 D12420  Licaminlimab (USAN/INN)
DBLINKS     CAS: 1688648-13-6
///
